image
Viracta Therapeutics, Inc. VIRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.151
-4.37 %
$ 5.95 M
Market Cap
-0.13
P/E
BALANCE SHEET
56.7 M ASSETS
-40.94%
Growth Rates
1Year -40.94%
3Years 5.48%
5Years 29.91%
7Years 3.95%
10Years 3.41%
38.4 M LIABILITIES
9.99%
Growth Rates
1Year 9.99%
3Years -25.95%
5Years 27.63%
7Years 8.12%
10Years -1.95%
18.3 M EQUITY
-70.02%
Growth Rates
1Year -70.02%
3Years 33.82%
5Years 35.62%
7Years -1.95%
10Years 17.37%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Viracta Therapeutics, Inc.
image
Current Assets 55 M
Cash & Short-Term Investments 53.7 M
Receivables 281 K
Other Current Assets 992 K
Non-Current Assets 1.73 M
Long-Term Investments 0
PP&E 464 K
Other Non-Current Assets 1.26 M
Current Liabilities 38.4 M
Accounts Payable 2.44 M
Short-Term Debt 25.8 M
Other Current Liabilities 10.1 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005
ASSETS
Cash & Cash Equivalents 12.3 36.8 103.6 47.1 18.3 13.7 27.0 8.1 26.9 22.2 15.1 14.9 9.3 14.2 4.3 6.3 11.7 6.1 17.7
Short Term Investments 41.4 54.3 0 0 16.4 0 4.8 34.5 19.5 20.8 24.2 56.3 34.8 39.2 0 4.3 36.0 57.0 30.6
Receivables 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 (0.9) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.9 4.5 3.4 0.2 1.7 1.5 1.2 0.6 0.6 1.2 1.2 1.7 1.6 1.3 0.6 0.9 0.9 1.1 2.1
Total Current Assets 55.0 93.7 105.3 47.2 36.3 15.2 32.9 43.2 47.0 44.2 40.5 72.9 45.7 54.7 4.8 11.6 48.6 64.2 50.4
PP&E 0.5 0.4 0.9 1.0 0.8 11 K 20 K 3 K 14 K 42 K 23 K 43 K 74 K 0.1 0.3 0.6 4.2 4.7 4.0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1.3 1.8 2.4 76 K 98 K (0.8) 1.4 0 0 0 10 K 42 K 0.1 60 K 64.4 K 0.6 0.4 0.4 0.3
Other Assets 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 56.7 96.0 108.6 48.3 37.2 15.3 34.3 43.2 47.0 44.2 40.5 73.0 45.9 54.9 5.2 12.8 53.2 69.3 54.7
LIABILITIES
Accounts Payable 2.4 2.5 2.9 1.6 0.8 1.4 1.7 1.9 2.5 3.2 1.0 78 K 0.7 0.4 0.4 0.8 1.5 2.5 2.0
Short Term Debt 25.8 0.6 0.8 1.4 6.0 7.4 7.2 3.3 7.8 9.3 9.0 6.6 0 0 0 0 1.0 0.9 1.1
Other Current Liabilities 10.1 6.9 5.4 3.4 2.5 2.5 3.8 5.1 6.3 12.0 16.0 17.1 7.7 12.1 2.6 5.4 5.3 3.3 3.3
Total Current Liabilities 38.4 10.0 9.1 6.3 9.4 11.3 12.7 10.9 19.0 27.9 34.0 31.7 8.4 12.6 3.0 6.2 8.9 8.9 10.2
Long Term Debt 0 24.9 5.4 4.8 0.3 0 0 11.1 0 0 9.0 17.7 9.5 0 0 0 1.4 1.0 1.3
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 5.2 (14.7) 0 0 0 0 0 (1 138.5) (3 314.2)
Other Liabilities 0 0 (0.3) 83.4 9 K 8 K 0.1 0.2 0 0 (5.2) 14.7 13 K 47.8 K 0 0.1 1.6 (2.1) (0.9)
Total Liabilities 38.4 34.9 14.2 94.5 9.7 11.3 12.8 22.2 19.6 30.4 46.7 61.1 17.8 12.6 3.1 6.3 11.9 12.5 16.2
EQUITY
Common Stock 4 K 4 K 4 K 1 K 11 K 4 K 3 K 2 K 9 K 7 K 5 K 5 K 5 K 4.54 K 3.59 K 3.44 K 3.44 K 2.94 K 2.15 K
Retained Earnings (265.9) (214.9) (165.7) (50.9) (682.8) (659.5) (632.9) (597.4) (559.4) (522.7) (479.7) (445.1) (401.1) (381.0) (356.4) (316.2) (279.0) (240.2) (209.0)
Other Accumulative Comprehensive Income/Loss 9 K (0.2) 0 (5.5) 1 K (21.0) 7 K 22 K 11 K 7 K 3 K 38 K (1.3) (1.8) (2.5) (8.4) (15.3) (14.1) (12.7)
Total Equity 18.3 61.1 94.4 (46.2) 27.5 4.0 21.5 21.0 27.4 13.8 (6.2) 12.0 28.0 42.2 2.1 6.5 41.4 56.8 38.5
Total Liabilities and Equity 56.7 96.0 108.6 48.3 37.2 15.3 34.3 43.2 47.0 44.2 40.5 73.0 45.9 54.9 5.2 12.8 53.2 69.3 54.7
SHARES OUTSTANDING
Common Shares Outstanding 38.6 37.8 31.9 92.8 K 2.5 1.0 0.7 0.4 0.3 1.0 0.9 0.8 0.8 0.4 95.5 K 95.5 K 89.8 K 77.1 K 63.8 K